Alzheon Inc.
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects (NCT06304883) | Alzheon Inc. | 2024-04-02 |
| An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects (NCT04770220) | Alzheon Inc. | 2021-05-19 |
| Biomarker Effects of ALZ-801 in APOE4 Carriers With Early Alzheimer's Disease (NCT04693520) | Alzheon Inc. | 2020-09-30 |
Track Alzheon Inc. automatically
Every clearance here is in the API, with alerts when new ones post.